Unspecified monoclonal antibody therapy (Phase 1)

· Mayo Clinic

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Unspecified monoclonal antibody therapy (Phase 1), covering 2017-05-25 to 2017-05-25. Get the full timeline:

Most recent: Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma [Phase 1]